http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Singhal, B.K.,Dhar, Anil,Sharma, Aradhana,Jand, Seema,Bindroo, B.B.,Saxena, N.N.,Khan, M.A. Korean Society of Sericultural Science 2003 International Journal of Industrial Entomology Vol.6 No.2
Mathematical constants for multiplication with leaf length (I) or breadth (b) or l ${\times}$ b have been worked out for determining leaf area in promising mulberry genotypes viz., Chinese White, S-146, Chak Majra and Sujanpur Local of sub-tropical India. When pooled, the mathematical constants worked out were 8.1132, 10.1019 and 0.5992 for multiplication with leaf length, breadth and l ${\times}$ b, respectively, for genotypes bearing un-lobbed leaves and 6.9447, 8.2761 and 0.5009 for multiplication with leaf length, breadth and l ${\times}$ b, respectively for genotypes bearing lobbed leaves. Leaf area can be worked out by using any constant by multiplying either with leaf length or breadth or both (l ${\times}$ b). Estimated leaf areas worked out were found significantly and positively correlated with actual leaf area (r=999$^{**}$). The suggested present non-destructive method by using mathematical constants is very quick and alternative to electronic leaf area meter for spot leaf area determination in mulberry which is the only food source for mulberry silkworm in sericulture industry.
Meeting Report: Translational Advances in Cancer Prevention Agent Development Meeting
Mark Steven Miller,Peter J. Allen,Powel H. Brown,Andrew T. Chan,Margie L. Clapper,Roderick H. Dashwood,Shadmehr Demehri,Mary L. Disis,Raymond N. DuBois,Robert J. Glynn,Thomas W. Kensler,Seema A. Khan 대한암예방학회 2021 Journal of cancer prevention Vol.26 No.1
The Division of Cancer Prevention of the National Cancer Institute (NCI) and the Office of Disease Prevention of the National Institutes of Health co-sponsored the Translational Advances in Cancer Prevention Agent Development Meeting on August 27 to 28, 2020. The goals of this meeting were to foster the exchange of ideas and stimulate new collaborative interactions among leading cancer prevention researchers from basic and clinical research; highlight new and emerging trends in immunoprevention and chemoprevention as well as new information from clinical trials; and provide information to the extramural research community on the significant resources available from the NCI to promote prevention agent development and rapid translation to clinical trials. The meeting included two plenary talks and five sessions covering the range from pre-clinical studies with chemo/immunopreventive agents to ongoing cancer prevention clinical trials. In addition, two NCI informational sessions describing contract resources for the preclinical agent development and cooperative grants for the Cancer Prevention Clinical Trials Network were also presented.